CD24-CAR-NK cells are activated following specific binding to the SWA11-antigenic recognition site, and elicit cytotoxic activity against CD24+ tumor cell lines (Skov-3, OVCAR3) and patient-derived primary ovarian cancer cells [98]. This evidence concerns the gene CD24 and neoplasm.